Resolute Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$476K Buy
1,947
+558
+40% +$130K 0.2% 45
2025
Q4
$287K Buy
1,389
+9
+0.7% +$1.78K 0.09% 53
2025
Q3
$256K Sell
1,380
-96
-7% -$16.4K 0.07% 58
2025
Q2
$225K Buy
1,476
+65
+5% +$9.99K 0.06% 59
2025
Q1
$234K Sell
1,411
-952
-40% -$149K 0.07% 50
2024
Q4
$342K Buy
2,363
+1,022
+76% +$158K 0.07% 47
2024
Q3
$217K Buy
+1,341
New +$214K 0.04% 49
2022
Q4
Sell
-6
Closed -$1K 96
2022
Q3
$1K Hold
6
﹤0.01% 135
2022
Q2
$1K Hold
6
﹤0.01% 125
2022
Q1
$1K Sell
6
-1,238
-100% -$211K ﹤0.01% 127
2021
Q4
$213K Sell
1,244
-704
-36% -$115K 0.01% 57
2021
Q3
$315K Sell
1,948
-542
-22% -$92.5K 0.04% 56
2021
Q2
$410K Buy
2,490
+1,773
+247% +$294K 0.06% 35
2021
Q1
$83K Buy
+717
New +$116K 0.01% 63

Other funds holding JNJ

Resolute Advisors's JNJ Position: Q1 2026 in Review

Resolute Advisors increased its Johnson & Johnson (JNJ) stake by 40% in Q1 2026, buying an estimated $130K and bringing the position to 1,947 shares worth $476K. The position accounts for 0.2% of the portfolio, ranked #45.

Resolute Advisors first reported a position in JNJ in Q1 2021 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Resolute Advisors held 1,947 shares of Johnson & Johnson worth $476K as of Q1 2026.
  • Resolute Advisors bought 558 Johnson & Johnson shares in Q1 2026, an estimated $130K.
  • Johnson & Johnson made up 0.2% of Resolute Advisors's portfolio in Q1 2026, its #45 holding.
  • Resolute Advisors first reported a position in Johnson & Johnson in Q1 2021 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Resolute Advisors's 13F filing for Q1 2026, filed 7 May 2026.